Skip to main content
SpringerLink
Log in

EOLIA-Studie

Bietet die ECMO einen Überlebensvorteil bei ARDS?

EOLIA trial

Does ECMO confer a survival advantage in ARDS?

  • Journal Club
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308

    Article  Google Scholar 

  2. Karagiannidis C, Brodie D, Strassmann S et al (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896

    Article  CAS  Google Scholar 

  3. Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lungenklinik Köln-Merheim; Kliniken der Stadt Köln gGmbH, ARDS und ECMO Zentrum, Universität Witten/Herdecke, Ostmerheimer Str. 200, 51109, Köln, Deutschland

    C. Karagiannidis

Authors
  1. C. Karagiannidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Karagiannidis.

Ethics declarations

Interessenkonflikt

Die Kliniken der Stadt Köln, Klinikum der Universität Witten/Herdecke, haben von der Firma Maquet eine Forschungsunterstützung zur Durchführung einer Studie zum Thema ECCO2R und NIV-NAVA erhalten. C. Karagiannidis erhielt Vortragshonorare von den Firmen Getinge und Bayer.

Additional information

Redaktion

S. Kluge, Hamburg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karagiannidis, C. EOLIA-Studie. Med Klin Intensivmed Notfmed 114, 164–165 (2019). https://doi.org/10.1007/s00063-018-0511-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-018-0511-1

Search

Navigation